Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study information regarding A4250 for Primary Biliary Cirrhosis, while retaining some key identifiers such as the study's location and collaborators.SummaryDifference34%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check86 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check100 days agoChange DetectedThe page now includes a notice about heavy traffic affecting NLM-NCBI services and mentions Sahlgrenska University Hospital, while the reference to Vastra Gotaland Region has been removed.SummaryDifference3%
- Check107 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.